Angiogenesis in cervical carcinoma

CME Journal of Gynecologic Oncology

Volumn 6, Issue 2, 2001, Pages 184-191

  Obermair, A ^a   Preyer, O ^a   Bachtiary, B ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Angiogenesis; Carcinoma; Prognostic significance; Uterine cancer

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; VASCULOTROPIN;

ANGIOGENESIS; CANCER SURVIVAL; CAPILLARY DENSITY; FEMALE; HUMAN; HYPOXIA; PROGNOSIS; REVIEW; SOLID TUMOR; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VASCULARIZATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0034776750     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
2. Tumor angiogenesis as a prognostic factor in cervical carcinoma
3. Prognostic value of tumor microvessel density in cancer of the uterine cervix stage IB to IIB
4. Tumor vascularity - A novel prognostic factor in advanced cervical carcinoma
5. Angiogenesis in uterine cervical squamous cell carcinoma
6. Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix
7. Tumor angiogenesis: An independent prognostic parameter in cervical cancer
8. The impact of tumor angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma
9. Angiogenesis in cervical neoplasia: Microvessel quantification in precancerous lesions and invasive carcinomas with clinicopathological correlations
10. Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survival
11. Apoptosis and tumor angiogenesis in cervival cancer after preoperative chemotherapy
12. Uterine cervical carcinoma: Comparison of standard and pharmakokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival
13. Expression of p150 in cervical neoplasia and its potential value in predicting survival
14. Angiogenesis in adenocarcinoma of the uterine cervix
15. High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy
16. Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma - Clinicopathologic correlation
17. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma
18. Expression of thymidine phosphorylase in human cervical cancer
19. Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence
20. Thymidine phosphorylase expression in tumor stroma of uterine cervical carcinoma: Histological features and microvessel density
21. Endoglin expression as a measure of microvessel density in cervical cancer
22. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer
23. Demonstration and characterization of the angiogenic properties of cervical dysplasia
24. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia
25. Angiogenesis in squamous cell carcinoma in situ and microinvasive carcinoma of the uterine cervix
26. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions
27. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia
28. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia
29. Angiogenesis in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: An immunohistochemical study
30. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
31. Intratumor microvessel density as a prognostic factor in cancer
32. Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery
33. Molecular and biological properties of vascular endothelial growth factor
34. Vascular endothelial growth factor is a secreted angiogenic mitogen
35. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
36. Vascular endothelial growth factor (VEGF) and ist receptors
37. Regulation of angogenesis via vascular endothelial growth factor receptors
38. Vascular endothehal growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
39. Hypoxic stimulation of vascular endothelial growth factor expression in vivo and in vitro
40. A quantitative analysis of reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines
41. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
42. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
43. Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation
44. Different angiogenic pathways in human cervical cancers
45. Vascular endothelial growth factor is implicated in early invasion in cervical cancer
46. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers
47. Vascular endothelial growth factor in cervical carcinoma
48. Vascular endothelial growth factor expression in progression of cervical cancer: Correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis
49. Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix
50. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix
51. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
52. Hypoxic cervical cancers with low apoptotic index are highly aggressive
53. Oxygenation predicts radiation response and survival in patients with cervix cancer
54. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix
55. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization
56. Oxygen tension and prediction of the radiation response. Polarographic study in human breast cancer
57. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
58. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy
59. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
60. The oxygen effect
61. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
62. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors
63. Regulation of mammalian 02 homeostasis by hypoxia-inducible factor 1
64. Hypocia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis
65. Overexpression of hypoxia-inducible factor lalpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer